Page last updated: 2024-08-16

salmeterol xinafoate and Cardiovascular Stroke

salmeterol xinafoate has been researched along with Cardiovascular Stroke in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Furberg, CD; Loke, YK; Singh, S	1
Cazzola, M; Donner, CF; Matera, MG	1
Achtari Jeanneret, L; Barras-Moret, AC; Carron, P; Deriaz-Chessex, S; Donzé, J; Fournier, Y; Gachoud, D; Moix, PA; Monti, M; Rossier, A; Wilson, P	1

Reviews

1 review(s) available for salmeterol xinafoate and Cardiovascular Stroke

Article	Year
Inhaled beta2-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung disease. Drugs, 2005, Volume: 65, Issue:12 Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Albuterol; Asthma; Cardiovascular Diseases; Clinical Trials as Topic; Ethanolamines; Formoterol Fumarate; Heart; Heart Failure; Humans; Metered Dose Inhalers; Myocardial Infarction; Myocardium; Pulmonary Disease, Chronic Obstructive; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate	2005

Article

Year

Inhaled beta2-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung disease.

Drugs, 2005, Volume: 65, Issue:12

Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Albuterol; Asthma; Cardiovascular Diseases; Clinical Trials as Topic; Ethanolamines; Formoterol Fumarate; Heart; Heart Failure; Humans; Metered Dose Inhalers; Myocardial Infarction; Myocardium; Pulmonary Disease, Chronic Obstructive; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate

2005

Other Studies

2 other study(ies) available for salmeterol xinafoate and Cardiovascular Stroke

Article	Year
Outpatient management of severe COPD. The New England journal of medicine, 2010, 07-29, Volume: 363, Issue:5 Topics: Administration, Inhalation; Albuterol; Bronchodilator Agents; Drug Therapy, Combination; Humans; Myocardial Infarction; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate; Scopolamine Derivatives; Tiotropium Bromide	2010
[Highlights 2007 in hospital-based internal medicine: the point of view from the chief residents]. Revue medicale suisse, 2008, Jan-30, Volume: 4, Issue:142 Topics: Accidental Falls; Aged; Albuterol; Anemia; Anticoagulants; Antidiuretic Hormone Receptor Antagonists; Atrial Fibrillation; Attitude of Health Personnel; Benzazepines; Bronchitis, Chronic; Bronchodilator Agents; Cardiac Pacing, Artificial; Diabetes Mellitus; Endocarditis, Bacterial; Erythropoietin; Heart Failure; Heparin; Humans; Internal Medicine; Interprofessional Relations; Medical Staff, Hospital; Myocardial Infarction; Recombinant Proteins; Risk Management; Rosiglitazone; Salmeterol Xinafoate; Thiazolidinediones; Thromboembolism; Tolvaptan; Vasodilator Agents; Ventricular Dysfunction, Left; Workload	2008

Article

Year

Outpatient management of severe COPD.

The New England journal of medicine, 2010, 07-29, Volume: 363, Issue:5

Topics: Administration, Inhalation; Albuterol; Bronchodilator Agents; Drug Therapy, Combination; Humans; Myocardial Infarction; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate; Scopolamine Derivatives; Tiotropium Bromide

2010

[Highlights 2007 in hospital-based internal medicine: the point of view from the chief residents].

Revue medicale suisse, 2008, Jan-30, Volume: 4, Issue:142

Topics: Accidental Falls; Aged; Albuterol; Anemia; Anticoagulants; Antidiuretic Hormone Receptor Antagonists; Atrial Fibrillation; Attitude of Health Personnel; Benzazepines; Bronchitis, Chronic; Bronchodilator Agents; Cardiac Pacing, Artificial; Diabetes Mellitus; Endocarditis, Bacterial; Erythropoietin; Heart Failure; Heparin; Humans; Internal Medicine; Interprofessional Relations; Medical Staff, Hospital; Myocardial Infarction; Recombinant Proteins; Risk Management; Rosiglitazone; Salmeterol Xinafoate; Thiazolidinediones; Thromboembolism; Tolvaptan; Vasodilator Agents; Ventricular Dysfunction, Left; Workload

2008